Transformations of naproxen into pyrazolecarboxamides: Search for potent anti-inflammatory, analgesic and ulcerogenic agents

Medicinal Chemistry Research

Volumn 23, Issue 2, 2014, Pages 827-838

  El Sehemi, Abdullah G ^a   Bondock, Samir ^a,b   Ammar, Yousry A ^a,c  

^a KING KHALID UNIVERSITY   (Saudi Arabia)

^b Mansoura University   (Egypt)

^c Al Azhar University   (Egypt)

Author keywords

Anti inflammatory activity; Chalcones; Hydrazides; Naproxen; Pyrazoles

Indexed keywords

1,3 DIPHENYL PYRAZOL 4 YL; 3 PHENYL PYRAZOL 1 YL; 3,5 DIAMINO 4 (4 METHOXYPHENYLAZO) PYRAZOL L YL; 3,5 DIMETHYLPYRAZOL 1 YL; AMIDE; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; NAPROXEN DERIVATIVE; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG SCREENING; DRUG TRANSFORMATION; FEMALE; MALE; NONHUMAN; RAT;

EID: 84893806541     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-013-0650-0     Document Type: Article

References (36)

1. Almansa C, Alfon de Arriba J, Cavalcanti FL, Escamilla I (2003) Synthesis and structure-activity relationship of a new series of COX-2 selective inhibitors: 1,5-diarylimidazoles. J Med Chem 46:3463-3475
2. Al-Omran F, Al-Wadhi N, Abdel Khalil MM, Kaul K, Abu El-Khair A, Elnagdi MH, (1997) 1-Substituted-3-dimethylaminoprop-2-en-2-ones as building blocks in heterocyclic synthesis: routes to 6-aryl- and 6-heteroaryl-2H-pyran-2-ones and 6-and 4-arylpyridin-2(1H)-ones. J Chem Res (M): 601-615
3. Al-Sehemi AGM, El-Sharief AMSh, Ammar YA (2006) Propionic acids in organic synthesis: novel synthesis of benzimidazole, 3,1-benzoxazine, 3-aminoquinazoline and 3-aminothieno[2,3-d]pyrimidine derivatives containing 2-naphthyl propionyl moiety. Indian J Chem 45B:450
4. Amir M, Kumar H, Javed SA (2007) Anti-inflammatory and gastro sparing activity of some new indomethacin derivatives. Arch Pharm Chem Life Sci 340:577-585
5. Amr AE, Abdulla MM (2006) Synthesis and anti-inflammatory activities of new cyanopyrane derivatives fused with steroidal nuclei. Arch Pharm Chem Life Sci 339:88-95
6. Armitage P (1971) Statistical methods in medical research, 1st edn. Blackwell, Oxford, p 147
7. Blicke FF, Burckhalter JH (1942) The preparation of β-keto amines by the Mannich reaction. J Am Chem Soc 64:451-454
8. Cash JM, Klippel JH (1994) Second-line drug therapy for rheumatoid arthritis. N Engl J Med 330:1368-1375
9. Davies NM, Wallace JL (1997) Nonsteroidal anti-inflammatory drug-induced gastrointestinal toxicity: new insights into an old problem. J Gastroenterol 32(1):127-133
10. Duflos M, Nourrisson MR, Brelet J, Courant J, Le Baut G, Grimaud N, Petit JY (2001) N-pyridinyl-indole-3-(alkyl) carboxamides and derivatives as potential systemic and topical inflammation inhibitors. Eur J Med Chem 36:545-553
11. Farag AA, Khalifa EM, Sadik NA, Abbas SY, Al-Sehemi AG, Ammar YA (2013) Synthesis, characterization and evaluation of some novel 4(3H)-quinazolinone derivatives as anti-inflammatory and analgesic agents. Med Chem Res 22:440-452
12. Froravanti R, Bolasco A, Manna F, Rossi F, Orallo F, Ortuso F, Alcaro S, Cirilli R (2010) Synthesis and biological evaluation of N-substituted-3,5- diphenyl-2-pyrazoline derivatives as cyclooxygenase (COX-2) inhibitors. Eur J Med Chem 45:6135-6138
13. Hawkey C, Laine L, Simon T, Beaulieu A, Maldonado-Cocco J, Acevedo E, Shahane A, Quan H, Bolognese J, Mortensen E (2000) Comparison of the effect of rofecoxib, ibuprofen and placebo on the gastroduodenal mucosa of patients with osteoarthritis: a randomized, double blind, placebo-controlled trial. Arthritis Rheum 43:370-377
14. Jensen BS (1959) The synthesis of 1-phenyl-3-methyl-4-acyl-pyrazolones-5. Acta Chem Scand 13:1668-1675
15. Kalgutkar AS, Marnett AB, Crews BC, Remmel RP, Marnett LJ (2000) Ester and amide derivatives of the nonsteroidal antiinflammatory drug, indomethacin, as selective cyclo-oxygenase-2 inhibitor. J Med Chem 43:2860-2870
16. Kimmey MB (1992) NSAIDS, ulcers, and prostaglandins. J Rheumatol 19:68-73
17. Kira MA, Abdel-Rahman MO, Gadalla KZ (1969) The vilsmeier-haack reaction-III cyclization of hydrazones to pyrazoles. Tetrahedron Lett 2:109-110
18. Lanza FL (1998) A guideline for the treatment and prevention of NSAID-induced ulcers. Am J Gastroenterol 93:2037-2046
19. Machado P, Rosa FA, Rossatto M, Sant'Anna GS, Sauzem PD, Silva RMS, Rubin MA, Ferreira J, Bonacorso HG, Zanatta N, Martinsa MAP (2007) Synthesis and structure of novel 4,5-dihydro-1H-pyrazoles: salicylic acid based analgesic agents. ARKIVOC xvi: 281-297
20. Marnett LJ, Kalgutkar AS (1998) Design of selective inhibitors of cyclooxygenase-2 as nonulcerogenic anti-inflammatory agents. Curr Opin Chem Biol 2(4):482-490
21. Marnett LJ, Kalgutkar AS (1999) Cyclooxygenase 2 inhibitors: discovery, selectivity and the future. Trends Pharmacol Sci 20:465-469
22. Mathew A, Sheej M, Kumar A, Radh K (2011) Design, synthesis and biological evaluation of pyrazole analogues of natural piperine hygeia. J D Med 3:48-56
23. Meng L, Mohan R, Kwok BHB, Elofssof M, Sin N, Crews CM (1999) Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo anti-inflammatory activity. Proc Natl Acad Sci USA 96:10403-10408
24. Obukowics MG, Walseh DJ, Salsgiver WJ, Martin-Berger CL, Chinn KS, Duffin KL, Ras A, Needleman P (1998) Novel selective delta 6 or delta 5 fatty acid desaturase inhibitors as anti-inflammatory agents in mice. J Pharmacol Exp Ther 287:157-166
25. Piazza GA, Keeton AB, Tinsley HN, Gary BD, Whitt JD, Mathew B, Thaiparambil J, Coward L, Gorman G, Li Y, Sani B, Hobrath JV, Maxuitenko YY (2009) A novel sulindac derivative that does not inhibit cyclooxygenases but potently inhibits colon tumor cell growth and induces apoptosis with antitumor activity. Cancer Prev Res 2:572-580
26. Reitz DB, Li JJ, Norton MB, Reinhard EJ, Collins JT, Anderson GD, Gregory SA, Koboldt CM, Perkins WE, Seibert K, Isakson PC (1994) Selective cyclooxygenase inhibitors: novel 1,2-diarylcyclopentenes are potent and orally active COX-2 inhibitors. J Med Chem 37:3878-3984
27. Smith CJ, Zhang Y, Koboldt CM, Muhammad J, Zwefel BS, Shaffer A, Talley JJ, Masferrer JL, Serbert K, Isakson PC (1998) Pharmacological analysis of cyclo-oxygenase-1 in in-flammation. Proc Natl Acad Sci USA 95:13313-13318
28. Stanovic B, Svete J (2004) Synthesis of heterocycles from alkyl 3-(dimethylamino)propenoates and related enaminones. Chem Rev 104:2433-2480
29. Steiner B, Koos M, Matulova M, Proksa B (1993) Synthesis of 2-acetyl-3-methyl-4H-1,4-benzothiazine and its derivatives. Monatsh Chem 124:425-430
30. Sukuroglu M, Ergun BC, Unlu S, Sahin MF, Kupeli E, Yesilada E, Banoglu E (2005) Synthesis, analgesic and anti-inflammatory activity of [6-(3,5-dimethyl-4-chloro pyrazole-1-yl)-3 (2H)-pyridazinon-2-yl]. Arch Pharm Res 28:509-517
31. Tsai PC, Wang IJ (2005) Synthesis and solvatochromic properties of some disazo dyes derived from pyrazolo[1,5-a]pyrimidine derivatives. Dyes Pigment 64:259-264
32. Wallace JL (1997) Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years. Gastroenterology 112:1000-1016
33. Warner TD, Giuliano F, Vaynovie I, Bukasa A, Mitchell JA, Vave JR (1999) Non-steroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastro-intestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci USA 96:7563-7568
34. Winter GA, Rislfy EA, Nuss GW (1962) Carrageenin-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med 111:544-547
35. Woolfe G, MacDonald AD (1944) Evaluation of analgesic action of pethidine hydrochloride (Demerol). J Pharmacol Exp Ther 80:300-307
36. Youssef AM, White MS, Villanueva EB, El-Ashmawy IM, Klegeris A (2010) Synthesis and biological evaluation of novel pyrazolyl-2,4-thiazolidinediones as anti-inflammatory and neuroprotective agents. Bioorg Med Chem 18:2019-2028